Take2 Prophecy™ test is a non-invasive early screening test for nasopharyngeal cancer. Through blood examination, it identifies early NPC patients by analyzing human and NPC-associated genomic signatures of EBV DNA in the blood plasma using a combination of Polymerase Chain Reaction (PCR) and Next-generation Sequencing (NGS) technologies.
✔ Take2 Prophecy™ blood examination
✔ Doctor consultation
Screening process :
1. Customer to collect a blood sample in the clinic
2. The blood sample will be sent to the laboratory for analysis
3. Screening results will be ready within 3-7 working days
4. Report analysis by a designated doctor
- If the test result is positive, you are recommended to consult a specialist for further investigation
- If the test result is negative, you are recommended to perform screening regularly or per your doctor’s advice.